参考文献/References:
[1]Yang Y,Reincke M,Williams TA. Prevalence,diagnosis and outcomes of treatment for primary aldosteronism[J]. Best Pract Res Clin Endocrinol Metab,2020,34(2):101365.
[2]Parasiliti-Caprino M,Lopez C,Prencipe N,et al. Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension[J]. J Hypertens,2020,38(9):1841-1848.
[3]Frustaci A,Letizia C,Verardo R,et al. Primary aldosteronism-associated cardiomyopathy:clinical-pathologic impact of aldosterone normalization[J]. Int J Cardiol,2019.
[4] Buffolo F,Tetti M,Mulatero P,et al. Aldosterone as a mediator of cardiovascular damage [J]. Hypertension,2022,79(9):1899-1911.
[5] Xu Z,Yang J,Hu J,et al. Primary aldosteronism in patients in china with recently detected hypertension [J]. J Am Coll Cardiol,2020,75(16):1913-1922.
[6] López-Andrés N,Martin-Fernandez B,Rossignol P,et al. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone [J]. Am J Physiol Heart Circ Physiol,2011,301(6):H2372-H2382.
[7] Hung CS,Chang YY,Tsai CH,et al. Aldosterone suppresses cardiac mitochondria [J]. Transl Res,2022,239:58-70.
[8] Liao CW,Chou CH,Wu XM,et al. Interleukin-6 plays a critical role in aldosterone-induced macrophage recruitment and infiltration in the myocardium [J]. Biochim Biophys Acta Mol Basis Dis,2020,1866(3):165627.
[9] Hung CS ,Chou CH,Liao CW,et al. Aldosterone induces tissue inhibitor of metalloproteinases-1 expression and further contributes to collagen accumulation:from clinical to bench studies[J]. Hypertension,2016,67(6):1309-1320.
[10] Voigt JU,Cvijic M. 2-and 3-Dimensional myocardial strain in cardiac health and disease[J]. JACC Cardiovasc Imaging,2019,12(9):1849-1863.
[11] Collier P,Phelan D,Klein A. A test in context:myocardial strain measured by speckle-tracking echocardiography[J]. J Am Coll Cardiol,2017,69(8):1043-1056.
[12] Kouzu H,Yuda S,Muranaka A,et al. Left ventricular hypertrophy causes different changes in longitudinal,radial,and circumferential mechanics in patients with hypertension:a two-dimensional speckle tracking study [J]. J Am Soc Echocardiogr,2011,24(2):192-199.
[13] Boulestreau R,Cremer A,Delarche N,et al. [Alteration of left ventricular longitudinal systolic function in 2D-strain in primary aldosteronism: a new target organ damage marker] [J]. Ann Cardiol Angeiol (Paris),2018,67(5):315-320.
[14] Chen ZW,Huang KC,Lee JK,et al. Aldosterone induces left ventricular subclinical systolic dysfunction:a strain imaging study [J]. J Hypertens,2018,36(2):353-360.
[15] Wang D,Xu JZ,Chen X,et al. Speckle-tracking echocardiographic layer-specific strain analysis on subclinical left ventricular dysfunction in patients with primary aldosteronism [J]. Am J Hypertens,2019,32(2):155-162.
[16] Brown JM,Wijkman MO,Claggett BL,et al. Cardiac structure and function across the spectrum of aldosteronism:the atherosclerosis risk in communities study [J]. Hypertension,2022,79(9):1984-1993.
[17] Tadic M,Sala C,Carugo S,et al. Left ventricular global longitudinal strain in secondary hypertension:a meta-analysis of echocardiographic studies [J]. Eur J Intern Med,2022,96:81-89.
[18] Omidkhoda N,Vakilian F,Mohammadpour AH,et al. Aldosterone and mineralocorticoid receptor antagonists on pulmonary hypertension and right ventricular failure:a review [J]. Curr Pharm Des,2020,26(3):3862-3870.
[19] Chen YL,Xu TY,Xu JZ,et al. A speckle tracking echocardiographic study on right ventricular function in primary aldosteronism [J]. J Hypertens,2020,38(11):2261-2269.
[20] Roemer S,Jaglan A,Santos D,et al. The utility of myocardial work in clinical practice [J]. J Am Soc Echocardiogr,2021,34(8):807-818.
[21]Chen YL,Xu TY,Xu JZ,et al. A non-invasive left ventricular pressure-strain loop study on myocardial work in primary aldosteronism[J]. Hypertens Res,2021,44(11):1462-1470.
[22]Meyh?fer S,Schmid SM,Hohl M,et al. Disturbed ventricular-arterial coupling and increased left atrial stiffness in a patient with heart failure with preserved ejection fraction and hyperaldosteronism:a case report[J]. Eur Heart J Case Rep,2019,3(4):1-6.
[23]Wang D,Xu JZ,Chen X,et al. Left atrial myocardial dysfunction in patients with primary aldosteronism as assessed by speckle-tracking echocardiography[J]. J Hypertens,2019,37(10):2032-2040.
[24]Ambale-Venkatesh B,Lima JA. Cardiac MRI:a central prognostic tool in myocardial fibrosis[J]. Nat Rev Cardiol,2015,12(1):18-29.
[25]Hinojar R,Varma N,Child N,et al. T1 mapping in discrimination of hypertrophic phenotypes:hypertensive heart disease and hypertrophic cardiomyopathy:findings from the international T1 multicenter cardiovascular magnetic resonance study[J]. Circ Cardiovasc Imaging,2015,8(12):e003285.
[26] Kuruvilla S,Janardhanan R,Antkowiak P,et al. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease,not hypertension alone [J]. JACC Cardiovasc imaging,2015,8(2):172-180.
[27] Pan JA,Micha?lsson E,Shaw PW,et al. Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease [J]. J hypertens,2019,37(1):65-72.
[28]Freel EM,Mark PB,Weir RA,et al. Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism:a cardiac magnetic resonance imaging study[J]. Circ Cardiovasc Imaging,2012,5(6):740-747.
[29]Chen YL,Chen CH,Xu TY,et al. Non-invasive left ventricular pressure-strain loop study on cardiac fibrosis in primary aldosteronism:a comparative study with cardiac magnetic resonance imaging[J]. Hypertens Res,2024,47(2):445-454.
[30]Su MY,Wu VC,Yu HY,et al. Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism[J]. J Magn Reson Imaging,2012,35(6):1349-1355.
[31]Redheuil A,Blanchard A,Pereira H,et al. Aldosterone-related myocardial extracellular matrix expansion in hypertension in humans:a proof-of-concept study by cardiac magnetic resonance[J]. JACC Cardiovasc imaging,2020,13(10):2149-2159.
[32]Wu T,Ren Y,Wang W,et al. Left ventricular remodeling in patients with primary aldosteronism:a prospective cardiac magnetic resonance imaging study[J]. Korean J Radiol,2021,22(10):1619-1627.
[33] Grytaas MA,Sellev?g K,Thordarson HB,et al. Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism [J]. Endocr Connect,2018,7(3):413-424.
[34] Zhou F,Wu T,Wang W,et al. CMR-verified myocardial fibrosis is associated with subclinical diastolic dysfunction in primary aldosteronism patients [J]. Front Endocrinol (Lausanne),2021,12:672557.
[35]Abe M,Hamada M,Matsuoka H,et al. Myocardial scintigraphic characteristics in patients with primary aldosteronism[J]. Hypertension,1994,23(1 Suppl):I164-I167.
[36] Napoli C,Di Gregorio F,Leccese M,et al. Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism:the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study[J]. J Investig Med,1999,47(5):212-221.
[37] Mulatero P,Monticone S,Deinum J,et al. Genetics,prevalence,screening and confirmation of primary aldosteronism:a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension[J]. J Hypertens,2020,38(10):1919-1928.
[38]Cheng J,Ma R,Dai R,et al. Comparison of cardiac structural improvement in patients with primary aldosteronism after surgical therapy and drug therapy:a meta-analysis[J]. Open J Endocrine Metab Dis,2022,12:283-295.
[39] Ueda T,Tsurutani Y,Osada J,et al. Comparison of echocardiographic changes between surgery and medication treatment in patients with primary aldosteronism [J]. J Am Heart Assoc,2022,11(13):e023813.
[40] Lin YH,Lee HH,Liu KL,et al. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy [J]. Surgery,2011,150(3):526-533.
[41] Lin YH,Wu XM,Lee HH,et al. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism [J]. J Hypertens,2012,30(8):1606-1613.
[42] Chen YL,Xu TY,Xu JZ,et al. A Prospective comparative study on cardiac alterations after surgery and drug treatment of primary aldosteronism [J]. Front Endocrinol (Lausanne),2021;12:770711.
[43] Puar TH,Cheong CK,Foo RSY,et al. Treatment of primary aldosteronism and reversal of renin suppression improves left ventricular systolic function [J]. Front Endocrinol (Lausanne),2022,13:916744.